Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Cellcept on the progression of diabetic nephropathy
2008-003768-20Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mycophenolate mofetil in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Primary endpoint: Change in urinary albumin/creatinine ratio. Started Jun 2008; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-003768-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003768-20.